Selenium Or Compound Thereof Patents (Class 424/702)
-
Publication number: 20080075710Abstract: An herbal composition is adapted to treat hangovers. In one embodiment, the herbal composition comprises potassium, thiamin (vitamin B-1), magnesium, silymarin and N-acetyl-L-cysteine (acetylcysteine), or any pharmaceutically acceptable salts thereof. In a method of treating hangovers, an herbal composition is provided that comprises potassium, thiamin, magnesium, silymarin and N-acetyl-L-cysteine. The herbal composition is placed in the body so as to alleviate or reduce the effects of a hangover.Type: ApplicationFiled: September 11, 2007Publication date: March 27, 2008Inventors: Erik T. Cornett, Gerad A. Harsy
-
Patent number: 7341734Abstract: A personal care composition that includes a personal care ingredient and semiconductor nanocrystals. A method of protecting at least a portion of a body against ultraviolet radiation by applying a personal care composition is also provided.Type: GrantFiled: November 22, 2005Date of Patent: March 11, 2008Assignee: Evident TechnologiesInventors: Jennifer Gillies, Margaret Hines
-
Publication number: 20080057136Abstract: The invention relates to antimicrobial compositions that can be used for disinfecting and can be applied in various aspects of the national economy, medicine, and laboratories of all types. The antimicrobial compositions comprise a chelating metal complex compound with a monodentate bidentate or polydentate ligand that exhibits affinity to hydrogen ion, an ionogenic surfactant, and a solvent. The compositions of the invention display antiseptic properties. The antimicrobial compositions are active against Gram-positive and Gram-negative bacteria, fungi, viruses, and spores, and can be applied in a broad temperature interval. Methods of using the compositions of the present invention in the treatment and prevention of diseases caused by a variety of pathogens are further provided.Type: ApplicationFiled: November 11, 2004Publication date: March 6, 2008Applicant: Veckis Industries Ltd.Inventors: Victor S. Polyakov, Valeriy V. Ermilov, Vladimir S. Kuzmin, Oleg I. Lukashov
-
Patent number: 7335384Abstract: The present disclosure describes a novel composition for the treatment and/or prevention of neurogenic inflammation. Such composition is also useful in the treatment and/or prevention of disease states and conditions associated with neurogenic inflammation. Such disease states and conditions include, but are not limited to, migraine headache, arthritis and fibromyalgia. The composition comprises nutrient compounds in a novel combination and formulation to treat and/or prevent neurogenic inflammation and disease states and conditions associated therewith. By reducing neurogenic inflammation, the compositions of the present disclosure reduce the symptoms associated with neurogenic inflammation, such as pain and systemic inflammation in general.Type: GrantFiled: March 17, 2006Date of Patent: February 26, 2008Assignee: 4K Nutripharma InternationalInventor: F. Mahnaz Khaled
-
Publication number: 20080038367Abstract: The present invention relates to a nutritional supplement composition and methods for preparing. The invention further provides a method for creating a nutrient supplement drink composition comprising the a carrier liquid, a flower distillate, and at least one herbal extract component, and optionally including an additional ingredient selected from the group consisting of a second herbal extract component, a nutrient, a flavoring agent, a preservative, a coloring agent, a second carrier agent, and combinations thereof.Type: ApplicationFiled: August 11, 2006Publication date: February 14, 2008Inventor: Sal Saloum
-
Patent number: 7304038Abstract: Disclosed is a therapeutic nutritional compound for treating and supporting the immune response in a mammal, particularly a human baby or child, and the treatment method. Additionally, the therapeutic nutritional compound can be used in conjunction with a vaccine or immunization regimen to reduce the potential undesirable effects caused by other components of the vaccine. The therapeutic nutritional compound can include glutathione, selenium, zinc and antioxidants.Type: GrantFiled: September 9, 2005Date of Patent: December 4, 2007Inventor: Julie A. Buckley
-
Patent number: 7288271Abstract: The present invention relates to a preparation for stimulating or enhancing an immune system comprising one or more agents that stimulate T-lymphocytes in vivo. Such a preparation can be sued in the prophylaxis and/or treatment of a medical condition. The invention further relates to a preparation for use in a pharmaceutical or food product and to a preparation for medical use.Type: GrantFiled: July 2, 2003Date of Patent: October 30, 2007Assignee: Nutricia N.V.Inventors: Yvo Maria Franciscus Graus, Hobbe Friso Smit, Albertus Dominicus Marcellinus Erasmus Osterhaus, Robert Johan Joseph Hageman
-
Publication number: 20070248651Abstract: A vitamin, mineral, herbal, and micronutrient treatment for acne via support of the physiologic processes in the body which cause acne is disclosed. It is a targeted formula, designed specifically to address the causes of acne. This specific, unique formulation preferably in a gummy substrate for ease of administration, to induce a willingness on the part of the target population to take it, and to increase the bioavailability of the active ingredients. Other types of confection or edible vehicle can be used.Type: ApplicationFiled: July 7, 2006Publication date: October 25, 2007Inventors: Ellie Sawits, Peter C. Dea, Laura Tringale
-
Patent number: 7285292Abstract: The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium and which comprises a concentration of the metal(s) of at least 60 mg/ml. The solution further comprises at least one compound selected from the group comprising iodine, potassium iodide, sodium iodide, iron, iron chloride, zinc oxide, manganese sulphate, sodium selenite, copper carbonate, sodium carbonate, anhydrous disodium EDTA and sodium hydroxide. The trace element solution is prepared by a method consisting essentially of the steps of preparing a MnCO3 mixture in a container; adding an EDTA/NaOH mixture to the container and subsequently adding at least one metal compound; and adding Na2SeO3 to the container to obtain the trace element solution. The method also comprises the step of adding CrCl3.6H2O to the trace element solution.Type: GrantFiled: April 29, 2004Date of Patent: October 23, 2007Assignee: Warburton Technology LimitedInventors: Robert Naylor Laurie, William Alfred Smith
-
Publication number: 20070231312Abstract: Preeclampsia and intrauterine growth restriction in a pregnant female mammal are prevented or decreased in severity by administering thereto a combination of a vitamin compound containing B1, Folic Acid (or active form 5-Methyl-Tetrahydrofolate i.e.; Metafolin®), B 6 (Pyridoxine or active form Pyridoxine 5-Phosphate P5P), B 12, Ascorbic Acid, Selenium, Zinc, Co-enzyme Q 10 and N-Acytyl Cysteine, Lycopene, optionally in further combination with Melatonin and/or Vitamin E or/and ASA 81 mg both of later, are cyclooxygenase inhibitors, a PGI.sub.2-mimetic, a thromboxane (TXA.sub.2) inhibitor, a compound possessing TXA.sub.2-agonistic and TXA.sub.2-inhibiting properties, a compound possessing TXA.sub.2-antagonistic and PGI.sub.2-mimetic activities, and a TXA.sub.2 antagonist.Type: ApplicationFiled: October 23, 2006Publication date: October 4, 2007Inventors: Michael V. Muench, Lori L. Muench, Steven M. Feld
-
Publication number: 20070202091Abstract: A nutraceutical composition and method for promoting the rejuvenation of cells in warm-blooded animals including humans employing mitochondrial energy production-inducing agent for inducing the mitochondrial energy production to proceed from a lower energy production state to a higher energy production state and a nutraceutical composition for supporting the metabolic requirements of the increased mitochondrial energy production induced by the mitochondrial energy production-inducing agent.Type: ApplicationFiled: February 27, 2007Publication date: August 30, 2007Inventor: Stephen L. DeFelice
-
Publication number: 20070196513Abstract: Compositions and related methods of Cissus quadrangularis plant extracts and soy albumin that improve various cardiovascular risk factors and metabolic risk factors that cause Syndrome X. In one exemplary embodiment, university studies demonstrated that a formulation of 300 mg Cissus quadrangularis plant extract, 3 mg niacin-bound chromium, 500 mg of green tea extract, 24 mg of selenium, 100 mg of soy albumin, 100 mg of vitamin B6, 0.1 mg of vitamin B12 and 0.8 mg of folic acid to obese and overweight humans daily for eight weeks provided unexpected synergistic results that improved a variety of health related factors.Type: ApplicationFiled: September 22, 2006Publication date: August 23, 2007Inventor: Shil C. Kothari
-
Patent number: 7205007Abstract: The invention provides a nutritional supplement system and program for patients undergoing or who have undergone a surgical or other invasive or stressful procedure, or who have suffered an injury. This nutritional supplement for the peri-operative period is designed to prevent deficiencies of nutrients needed for optimal health and healing during this period or for general application and to enable the person receiving the nutritional supplementation to achieve maximum healing and rapid recovery from a procedure or injury.Type: GrantFiled: October 4, 2005Date of Patent: April 17, 2007Assignee: Fairfield Clinical Trials, LLCInventor: Edward M. Lane
-
Patent number: 7205002Abstract: Pharmaceutical compositions containing elemental selenium (Se(0)), Se(0)-carrier conjugates, a chromophore photoproduct, fluorescent conjugates of the chromophore photoproduct and carrier molecules, or a mixture thereof are disclosed. Methods of using the pharmaceutical compositions such as inducing cell death are also disclosed. Further disclosed are methods of making the pharmaceutical compositions and components thereof.Type: GrantFiled: November 5, 2003Date of Patent: April 17, 2007Assignee: MCW Research Foundation, Inc.Inventors: Fritz Sieber, Wolfgang H. H. Günther, Jean-Pierre Daziano, Marianne Krieg-Kowald, Jamal Bousbaa, Raymond J. Bula
-
Patent number: 7186421Abstract: Mineral additives for preparing tablet compositions that comprise Vitamin E and optionally saw palmetto. The compositions are preferably formulated with a zinc compound and a selenium compound.Type: GrantFiled: September 29, 2004Date of Patent: March 6, 2007Assignee: ProEthic Pharmaceuticals, Inc.Inventors: Bryce M. Harvey, V. Stan Mader
-
Patent number: 7153877Abstract: A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and administering to them an effective amount of a composition comprising niacin-bound chromium that prevents or reduces the symptoms. Compositions incorporating niacin-bound chromium and additional compounds also are disclosed that are particularly effective in synergistically preventing or reducing these symptoms.Type: GrantFiled: December 9, 2004Date of Patent: December 26, 2006Assignee: Interhealth Nutraceuticals IncorporatedInventors: Debasis Bagchi, Harry G. Preuss, Shil C. Kothari
-
Patent number: 7119110Abstract: A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and administering to them an effective amount of a composition comprising niacin-bound chromium that prevents or reduces the symptoms. Compositions incorporating niacin-bound chromium and additional compounds also are disclosed that are particularly effective in synergistically preventing or reducing these symptoms.Type: GrantFiled: October 4, 2002Date of Patent: October 10, 2006Assignee: Interhealth Nutraceuticals IncorporatedInventors: Debasis Bagchi, Harry G. Preuss, Shil C. Kothari
-
Patent number: 7097859Abstract: A tablet for oral administration of nutritional indium comprises about 10–50 mg indium sulfate, about 4–20 mg caffeine, about 2–10% by weight cocoa powder, and about 5–10% by weight ethyl cellulose, in combination with about 50–150 ?g of each of zinc oxide, copper (II) oxide, magnesium oxide, potassium iodide, selenium amino acid chelate, chromium amino acid chelate and manganese amino acid chelate.Type: GrantFiled: April 5, 2004Date of Patent: August 29, 2006Inventors: Jacob C. Hack, Richard D. Tobias
-
Patent number: 7083810Abstract: A cosmetic preparation in gel form is described which contains undissolved, water-swollen polymer particles and at the interface with gaseous substances forms reversibly a grainy, uneven, light-scattering surface and at the interface with solids forms reversibly a smooth, level, non-light-scattering surface. Preferred gel formers are superabsorbing polymers. A preferred use is the hair-end protection in permanent wave treatment.Type: GrantFiled: April 7, 2001Date of Patent: August 1, 2006Assignee: Wella AktiengesellschaftInventors: Susanne Birkel, Juergen Allwohn, Harald Wendel, Michael Franzke, Birgit Schreiber, Axel Kalbfleisch
-
Patent number: 7078059Abstract: The invention provides a method for enhancing bone formation, inhibiting osteoclastic differentiation and/or activating osteoblastic differentiation whereby to manage, treat or achieve prophylaxis of bone disease which comprises administering to a human or animal subject suffering from, or susceptible to bone disease a therapeutically or prophylactically effective amount of a lanthanum compound.Type: GrantFiled: June 26, 2001Date of Patent: July 18, 2006Assignee: Shire Holdings AGInventors: Nigel D. Atherton, Joseph William Totten, Michael David Gaitonde
-
Patent number: 7063865Abstract: A composition that will substantially reduce the deleterious effects of alcohol on the body and substantially reduce the side effects associated with hangovers (i.e. headaches, dizziness, nausea, dry mouth, etc) when taken as recommended. The composition includes an effective amount of (I)-glycine, (I)-glutathione, thiamine, magnesium, selenium, molybdenum. Other vitamins, mineral compounds, flavoring, coloring, and solubility agents may also be added.Type: GrantFiled: May 10, 2002Date of Patent: June 20, 2006Inventors: Jeremy Park Jones, Peter Kevin Dobler
-
Patent number: 7060302Abstract: A metal-containing composition substantially comprising (i) at least one water soluble metal compound which forms metal ions when dissolved in water, (ii) at least one metal ion modifier as herein defined, (iii) at least one acid, and (iv) water said composition having a pH of less than 6 and an electrolytic potential in excess of 10 millivolts. Such compositions have uses in the prevention and/or treatment of pathogenic disease or disorder, as foodstuff supplements, in the treatment by disinfection of meat and other foodstuffs, in the coating, sealing and plating of metals, and treatment of water and sewage.Type: GrantFiled: August 31, 2000Date of Patent: June 13, 2006Assignee: Remedy Research LimitedInventor: Stephen Spaulding Hickok
-
Patent number: 7045151Abstract: In a new pharmaceutical combination, the herb, Vitex agnus-castus (chasteberry), enhances hormone balance by increasing progesterone release and, therefore, ovulation frequency. The antioxidants, green tea, vitamin E, and selenium, improve overall reproductive health. L-arginine, an amino acid, stimulates the reproductive organs by improving circulation. Folic acid, vitamins B6 and B12, iron, zinc and magnesium help promote womens' fertility. Sperms are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. Vitamins C and E, coenzyme Q10 and selenium are all potent antioxidants that help improve sperm counts and quality. Ferulic acid, an antioxidant found in Dong quai, also improves sperm quality. Zinc and B vitamins (B6, B12 and folate) are critical nutrients in male reproductive systems for hormone metabolism, sperm formation and motility. The amino acid, L-carnitine, promotes formation of healthy sperm.Type: GrantFiled: September 24, 2002Date of Patent: May 16, 2006Assignee: The Daily Wellness CompanyInventor: Aileen Sontag Trant
-
Patent number: 7041699Abstract: A nutrient pharmaceutical formulation composition useful for treating cancer comprising ascorbic acid, L-lysine, L-proline and at least one polyphenol compound selected from the group consisting of epigallocatechin gallate, epicatechin gallate, epigallocatechin, epicatechin, catechin and the use of the composition in treating cancer and other tumors are provided.Type: GrantFiled: January 13, 2003Date of Patent: May 9, 2006Assignee: Matthias RathInventors: Shrirang Netke, Aleksandra Niedzwiecki, Matthias Rath, Waheed M. Roomi
-
Patent number: 7026308Abstract: Disclosed are topical compositions for the treatment of microbial infections on the skin or scalp which include a polyvalent metal salt of pyrithione and include a metal ion source. Also disclosed are methods for treating microbial infections of the skin or scalp using such compositions.Type: GrantFiled: June 22, 2000Date of Patent: April 11, 2006Assignees: The Procter & Gamble Company, Arch Chemicals, Inc.Inventors: David Francis Gavin, Anthony Raymond Marchetta, John Daniel Nelson, Jr., George Polson, James Robert Schwartz, Patricia Aileen Turley
-
Patent number: 7022350Abstract: A dietary supplement for treating or preventing prostate disease and/or vascular disease including saw palmetto, d-alpha tocopherol, d-gamma tocopherol, d-delta tocopherol, d-beta tocopherol, selenium, lycopene, zinc, folic acid, vitamin B12, and vitamin B6, each in a therapeutically effective amount.Type: GrantFiled: April 27, 2004Date of Patent: April 4, 2006Assignee: Proethic Pharmaceuticals, Inc.Inventors: Bryce M. Harvey, Philip M. Knight
-
Patent number: 7018652Abstract: Nonalcoholic steatohepatitis (NASH) is a disease of the liver characterized by inflammation and damage to the liver cells. Typically, steatohepatitis involves inflammation of the liver related to fat accumulation, and mimics alcoholic hepatitis but is observed in patients who seldom or never consume alcohol. Nonalcoholic steatohepatitis can lead to serious liver damage, and ultimately cirrhosis. The present invention provides methods and compositions useful for the treatment or alleviation of nonalcoholic steatohepatitis and the pharmaceutical formulations for their administration to a human. Specifically, compositions comprised of lecithin, antioxidants and vitamin B complex are administered parenterally, most preferably by oral administration. Specific therapeutic formulations include admixtures of these compounds and specific dosage formulations include daily oral administrations of these compounds in tablet or powder forms.Type: GrantFiled: November 13, 2003Date of Patent: March 28, 2006Assignee: Viva America Marketing, Inc.Inventors: Houn Simon Hsia, David Fan
-
Patent number: 6989164Abstract: L-carnitine, an amino acid, improves sperm quality and motility. Ferulic acid, an antioxidant found in Dong quai, also improves sperm quality. Sperm are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. Vitamins C and E, green tea, and selenium are all potent antioxidants that help improve overall reproductive health. Zinc and B vitamins (B6, B 12 and folate) are critical nutrients in male reproductive systems for hormone metabolism, sperm formation and motility.Type: GrantFiled: April 8, 2002Date of Patent: January 24, 2006Assignee: The Daily Wellness CompanyInventor: Aileen Sontag Trant
-
Patent number: 6939566Abstract: Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having the formula R-M, wherein R is at least one organic chelating moiety and M is at least one metal ion which is microbicidal to at least one microorganism. These complexes can disrupt microorganism activities by penetrating the natural protecting bio-films of such microorganisms through the reaction of the R-group with the organic constituents of these microorganisms while releasing M into their intra-cellular media. Thus, this process exhibits its biocidal activities from the inside-out, contrary to other methods which rely on damaging the protective biofilms.Type: GrantFiled: January 17, 2001Date of Patent: September 6, 2005Inventors: Kareem I. Batarseh, Marwan Al-Kayed
-
Patent number: 6939893Abstract: The present invention discloses a method for enhancing the efficacy of anti-cancer agents. The method comprises administering to an individual, in need of such a treatment, an anti-cancer agent and a selenium compound. The selenium compounds may be administered before, during or after administration of the anti-cancer agent.Type: GrantFiled: December 10, 2002Date of Patent: September 6, 2005Assignee: Health Research, Inc.Inventors: Youcef M. Rustum, Shousong Cao, Farukh Durrani
-
Patent number: 6919330Abstract: The treatment of psychiatric or neurological disorders using selenium in combination with drugs used conventionally to treat such disorders is disclosed. The daily dose of selenium is between 10 ?g and 2000 ?g per day.Type: GrantFiled: February 7, 2003Date of Patent: July 19, 2005Assignee: Laxdale LimitedInventor: Krishnarao Sitaramrao Vaddadi
-
Patent number: 6905694Abstract: A personal care composition is composed of: (a) from about 0.1% to about 99% by weight of a vehicle system which comprises a hydrophobically modified nonionic water soluble polysaccharide polymer which comprises a water soluble polysaccharide polymer backbone and a hydrophobic moiety selected from the group consisting of 3-alkoxy-2-hydroxypropyl group wherein the allyl moiety is a straight or branch chain having 2-6 carbon atoms, C3-C7 alky aryl alkyl, alkyl aryl groups and mixtures thereof, wherein the ratio of the hydrophilic portion to the hydrophobic portion of the polymer is from about 2:1 to 1000:1, and (b) at least one other personal care ingredient. This compostion can be used in a wide range of personal care products such as shampoos, conditioners, hair coloring and styling agents, soaps, body washing agents, underarm products, lubricating agents, oral care products, denture adhesives, sunscreen agents, make-up products, and the like.Type: GrantFiled: May 12, 1997Date of Patent: June 14, 2005Assignee: Hercules IncorporatedInventor: Jashawant J. Modi
-
Patent number: 6881424Abstract: A highly acidic metalated organic acid composition and its preparation. The acidic composition can be prepared by mixing a monovalent or polyvalent cation and an organic acid in the presence of a strong oxyacid, wherein the resultant acidic composition is less corrosive to a ferrous metal than a solution of a mineral acid having the same acidic pH value as that of the acidic composition, and where in the acid composition is more biocidal than a mixture of the organic acid and a metal salt of the organic acid which mixture has the same acid normality value as that of the acidic composition. The acidic composition can be prepared by mixing at least one regenerating acid, at least one metal base, and at least one organic acid, wherein the amount of the regenerating acid is in excess of the equivalent amount of the metal base.Type: GrantFiled: September 5, 2000Date of Patent: April 19, 2005Assignee: Mionix CorporationInventors: Maurice Clarence Kemp, Robert Blaine Lalum, David E. Lewis, Robert H. Carpenter
-
Patent number: 6863904Abstract: The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoids, vitamin E, vitamin D, vitamin C, thiamine, riboflavin, niacin, folic acid, pyridoxine, biotin, pantothenic acid, cobalamin, magnesium, manganese, zinc, selenium, chromium, copper, alpha lipoic acid, and lutein, wherein the composition is free of added iron.Type: GrantFiled: October 14, 2003Date of Patent: March 8, 2005Assignee: Everett Laboratories, Inc.Inventors: John A. Giordano, Charles Balzer
-
Patent number: 6844012Abstract: The invention concerns the use of at least a molecule containing selenium, in an amount corresponding to a daily dose of about 2 to 40 mg, even 80 mg of atomic selenium equivalent, on its own or combined with other synergetic molecules for controlling oxidative stress and excessive inflammatory reaction: zinc, vitamin E, vitamin C, iron binder, glutathione precursor, copper and/or copper input binder, for preparing a medicine for treating severe systemic inflammatory response syndrome, in particular any acute infectious condition endangering the patient's life whether of bacterial, parasitic, fungal or viral origin, and any condition corresponding to a severe onset of inflammatory pathology bringing about an exacerbation of cytokine secretion. The invention is applicable in human and veterinary medicine.Type: GrantFiled: August 30, 1999Date of Patent: January 18, 2005Inventors: Xavier Forceville, Dominique Vitoux
-
Patent number: 6841173Abstract: Chemical formulations and methods for reducing muscle and joint soreness are disclosed. A representative chemical formulation includes compounds such as a selenium-compound, chondroitin sulfate, glucosamine, and/or methylsulfonylmethane. A representative method for reducing muscle and joint soreness includes administering the chemical formulation to a host.Type: GrantFiled: March 26, 2002Date of Patent: January 11, 2005Inventor: Peter L. Reynolds
-
Patent number: 6835401Abstract: The invention relates to a method for improving the cell protection which comprises the administration of a combination of the extracts of the plants Vitis vinifera and Lycopersicon esculentum with the vitamins C, E, beta-carotene and optionally selenium. Said combination can be used in the prevention of phatological conditions related in part to an overproduction of free radicals like aging, arteriosclerosis and cancer.Type: GrantFiled: July 14, 2003Date of Patent: December 28, 2004Assignee: Pharmaton SAInventor: Fabio Soldati
-
Publication number: 20040258674Abstract: A nutritional supplement for improving cardiovascular health via aiding in preventing, slowing the progression of and/or treating hypertension, the supplement comprising quercetin; and a method for aiding in preventing, slowing the progression of and/or treating hypertension are described.Type: ApplicationFiled: April 12, 2004Publication date: December 23, 2004Inventor: Thunder Jalili
-
Publication number: 20040253320Abstract: An easily absorbed and well tolerated proportional nutritional supplementation composition and method to be used in patients suffering from deficiency states due to bowel disease that may include malabsorption and inflammatory bowel disease. It is this unique proportional formulation of antacid, calcium, vitamins, minerals and simethicone in lactose free, sorbitol free, gluten free and hypo allergen solution that is the novel invention. This novel invention allows for nutrients to be readily absorbed with little or no side effects that may be experienced when taking conventional supplements. The supplementation contains amounts of vitamins and minerals that are commonly deficient in these states including magnesium, chromium, increased iron, increased folic acid, calcium and fat soluble vitamins.Type: ApplicationFiled: June 12, 2004Publication date: December 16, 2004Applicant: Medical Futures Inc.Inventor: Pardeep Nijhawan
-
Publication number: 20040253319Abstract: The present invention provides pharmaceutical compositions for alleviating pathological conditions in a post-menopausal woman, comprising lysine, proline, arginine, ascorbic acid, magnesium, green tea extract, N-acetyl-cysteine, selenium, copper, manganese and one pharmaceutical acceptable component selected from the group consisting of a carrier, a diluent, and an excipient, wherein the compositions contain 24-25 wt % lysine, 16-25 wt % ascorbic acid and 22-25 wt % green tea extract. A method of treatment using the pharmaceutical compositions are also disclosed.Type: ApplicationFiled: June 11, 2003Publication date: December 16, 2004Inventors: Shrirang Netke, Aleksandra Niedzwiecki, Matthias Rath, Vadim Ivanov
-
Publication number: 20040253323Abstract: An expeditious method and formula for treating a wide variety of cancer neoplasm's administering anti-tumor agents for reduction or elimination of the path physiological process of cancer cell proliferation and the creation of an acidic micro-environment, resulting in stabilization, control, suppression, remission and elimination of metastatic seeding. The invention employs controlling mechanisms of intracellular and extra cellular ionic physiology through the administration of alkaline salts, optimally restoring localized and or systemic cellular ionic physiology and depriving cancerous cells of their ability to grow rapidly and simultaneously normalizing their local ionic environment, thereby inhibiting angiogenesis, reducing metastatic proliferation, stimulating immune responses and reducing pain.Type: ApplicationFiled: June 14, 2004Publication date: December 16, 2004Inventor: Brian C. Giles
-
Patent number: 6831103Abstract: The present invention relates to a composition for suppressing or ameliorating a symptom accompanying diminished homeostasis, comprising theanine; and a mineral composition comprising theanine and a mineral. According to the present invention, there can be provided a composition for suppressing or ameliorating the above symptoms; and a mineral composition having a reduced peculiar metal taste, of which administration is made easily.Type: GrantFiled: September 5, 2000Date of Patent: December 14, 2004Assignee: Taiyo Kagaku Co., Ltd.Inventors: Tomoko Ueda, Yukiko Nagato, Yukiko Tanaka, Tsutomu Okubo, Kanari Kobayashi, Nobuyuki Aoi, Seiji Shu, Lekh Raj Juneja
-
Publication number: 20040219239Abstract: The present invention relates to the use of a composition comprising an oil with a high content of essential fatty acids of &ohgr;3 and &ohgr;6 type, preferably black current seed oil, and at least one compound selected from &bgr;-carotene, lycopene, tocopherol and its derivatives, tocotrienols and their derivatives, ascorbic acid and nicotinamide, as a nutritional supplement intended for preventing and/or combating the harmful effects of xenobiotics on the skin, in particular, on the skin's immune system.Type: ApplicationFiled: May 27, 2003Publication date: November 4, 2004Inventors: Dominique Castelli, Nathalie Issachar
-
Publication number: 20040213857Abstract: The invention relates to pharmaceutical or dietary unit dosage form, which can be swallowed easily, consisting essentially of vitamins, minerals and trace elements recommended for consumption by pregnant women, lactating women or women of childbearing potential that are attempting to become pregnant, DHA and a pharmaceutically or dietetically suitable carrier.Type: ApplicationFiled: April 15, 2004Publication date: October 28, 2004Applicant: Boehringer Ingelheim International GmbHInventors: Fabio Soldati, Lara Ambrosetti-Giudici
-
Publication number: 20040202699Abstract: As explained above, if and when the Solitonium is used in the products intended for weight reduction in accordance to the present invention, to ensure beneficial life for the humankind, then fat can be decomposed from the above-mentioned Solitonium and pain may be mitigated as well.Type: ApplicationFiled: May 30, 2003Publication date: October 14, 2004Inventor: Wu-Sung Kim
-
Publication number: 20040197283Abstract: Cosmetic/pharmaceutical compositions for promoting hair growth and/or retarding hair loss, and/or for increasing the mean diameter of strands of hair and/or decreasing the heterogeneity thereof, and/or for increasing hair density, and/or for improving the quality and/or the appearance of a head of hair, and/or for inducing repigmentation of the hair, contain thus effective amounts of intimate admixture of vitamin A, vitamin C, vitamin E, and zinc and selenium values.Type: ApplicationFiled: April 19, 2004Publication date: October 7, 2004Applicant: L'OREALInventors: Olivier De La Charriere, Francis Pruche
-
Patent number: 6800302Abstract: Compositions, optionally heat-activated, methods and kits for durable non-permanent shaping of at least one keratinous fiber or for durable retention of a non-permanent shape of at least one keratinous fiber comprising applying to keratinous fibers a composition comprising at least one compound chosen from C3 to C5 monosaccharides substituted with at least one C1 to C22 carbon chain, and heating the keratinous fibers.Type: GrantFiled: March 30, 2001Date of Patent: October 5, 2004Assignee: L'Oreal S.A.Inventors: David W. Cannell, Nghi Van Nguyen
-
Publication number: 20040180099Abstract: The present invention discloses a method for reducing the toxicity of anti-cancer agents oxaliplatin and doxorubicin. The method comprises administering to an individual, in need of such a treatment, the anti-cancer agent and a selenium compound. The selenium compounds may be administered before, during or after administration of the anti-cancer agent.Type: ApplicationFiled: December 12, 2003Publication date: September 16, 2004Inventors: Youcef M. Rustum, Shousong Cao, Farukh Durrani
-
Publication number: 20040170701Abstract: Therapeutic composition comprising (a) a physiologically acceptable source of assimilable copper; (b) salicylic acid or a physiologically acceptable derivative thereof; (c) vitamin C; and (d) a physiologically acceptable source of assimilable zinc; and method for the prevention or treatment of a respiratory disease, septicemia, cellulitis, AIDS, an autoimmune disease, or a bacteria or viral infection, in particular common cold or influenza, or for enhancing the immune system.Type: ApplicationFiled: April 1, 2004Publication date: September 2, 2004Inventor: John Carter
-
Patent number: RE39734Abstract: Nutritional or therapeutic compositions containing glutamic acid, cystine, glycine and a selenium precursor and methods for their utilization to increase glutathione synthesis and thereby enhance the immune system are described.Type: GrantFiled: July 13, 2005Date of Patent: July 17, 2007Inventor: Albert Crum